Do analysts prefer RDGT or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, RDGT or MEDS?

Ridgetech has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Wellgistics Health $23.34M 0.41 -$101.28M -$46.13 N/A

Is RDGT or MEDS more profitable?

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts prefer HKPD or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, HKPD or RDGT?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.14 -$1.14M N/A N/A Ridgetech $132.16M 0.03 -$1.25M N/A N/A

Is HKPD or RDGT more profitable?

Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Ridgetech N/A N/A N/A

Do analysts prefer RDGT or MCK?

McKesson has a consensus target price of $983.29, suggesting a potential upside of 4.87%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.79

Which has preferable earnings and valuation, RDGT or MCK?

McKesson has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A McKesson $403.43B 0.27 $4.76B $37.37 25.09

Is RDGT or MCK more profitable?

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A McKesson 1.12% -253.21% 5.90%

Does the media prefer RDGT or MCK?

In the previous week, McKesson had 42 more articles in the media than Ridgetech. MarketBeat recorded 44 mentions for McKesson and 2 mentions for Ridgetech. McKesson's average media sentiment score of 0.82 beat Ridgetech's score of 0.79 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 24 Very Positive mention(s) 11 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts rate COR or RDGT?

Cencora currently has a consensus price target of $372.07, indicating a potential upside of 14.98%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, COR or RDGT?

Cencora has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.19 $1.55B $13.46 24.04 Ridgetech $132.16M 0.03 -$1.25M N/A N/A

Does the media refer more to COR or RDGT?

In the previous week, Cencora had 17 more articles in the media than Ridgetech. MarketBeat recorded 19 mentions for Cencora and 2 mentions for Ridgetech. Cencora's average media sentiment score of 0.81 beat Ridgetech's score of 0.79 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 11 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate RDGT or CAH?

Cardinal Health has a consensus target price of $266.56, indicating a potential upside of 12.32%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts clearly believe Cardinal Health is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.84

Which has preferable earnings & valuation, RDGT or CAH?

Cardinal Health has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Cardinal Health $254.25B 0.22 $1.71B $7.23 32.83

Does the media prefer RDGT or CAH?

In the previous week, Cardinal Health had 9 more articles in the media than Ridgetech. MarketBeat recorded 11 mentions for Cardinal Health and 2 mentions for Ridgetech. Cardinal Health's average media sentiment score of 1.03 beat Ridgetech's score of 0.79 indicating that Cardinal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardinal Health 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Ridgetech (RDGT) Competitors

$1.01 +0.14 (+15.45%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.95 -0.06 (-5.94%)

As of 10/9/2026 07:58 PM Eastern

Compare

RDGT vs. MEDS, HKPD, MCK, COR, and CAH

Should you buy Ridgetech stock or one of its competitors? Ridgetech's main competitors and comparable companies include Wellgistics Health (MEDS), Hong Kong Pharma Digital Technology (HKPD), McKesson (MCK), Cencora (COR), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Ridgetech compare to Wellgistics Health?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 29.1% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Ridgetech had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Ridgetech and 1 mentions for Wellgistics Health. Ridgetech's average media sentiment score of 0.79 beat Wellgistics Health's score of 0.00 indicating that Ridgetech is being referred to more favorably in the media.

Company	Overall Sentiment
Ridgetech	Positive
Wellgistics Health	Neutral

Ridgetech has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Wellgistics Health	$23.34M	0.41	-$101.28M	-$46.13	N/A

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ridgetech has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, indicating that its stock price is 451% less volatile than the broader market.

Summary

Ridgetech beats Wellgistics Health on 8 of the 10 factors compared between the two stocks.

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.14	-$1.14M	N/A	N/A
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Hong Kong Pharma Digital Technology and Hong Kong Pharma Digital Technology both had 2 articles in the media. Ridgetech's average media sentiment score of 0.79 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Ridgetech is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
Ridgetech	Positive

Hong Kong Pharma Digital Technology has a beta of 2.57, meaning that its stock price is 157% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Ridgetech	N/A	N/A	N/A

45.3% of Ridgetech shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Ridgetech beats Hong Kong Pharma Digital Technology on 4 of the 7 factors compared between the two stocks.

How does Ridgetech compare to McKesson?

Ridgetech (NASDAQ:RDGT) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ridgetech has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

In the previous week, McKesson had 42 more articles in the media than Ridgetech. MarketBeat recorded 44 mentions for McKesson and 2 mentions for Ridgetech. McKesson's average media sentiment score of 0.82 beat Ridgetech's score of 0.79 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	24 Very Positive mention(s)	11 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

McKesson has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
McKesson	$403.43B	0.27	$4.76B	$37.37	25.09

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
McKesson	1.12%	-253.21%	5.90%

McKesson has a consensus target price of $983.29, suggesting a potential upside of 4.87%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

McKesson beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cencora?

Cencora (NYSE:COR) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Cencora has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Ridgetech	N/A	N/A	N/A

Cencora has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.46	24.04
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A

Cencora currently has a consensus price target of $372.07, indicating a potential upside of 14.98%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

97.5% of Cencora shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 0.4% of Cencora shares are owned by company insiders. Comparatively, 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cencora had 17 more articles in the media than Ridgetech. MarketBeat recorded 19 mentions for Cencora and 2 mentions for Ridgetech. Cencora's average media sentiment score of 0.81 beat Ridgetech's score of 0.79 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	11 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cencora beats Ridgetech on 13 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cardinal Health?

Ridgetech (NASDAQ:RDGT) and Cardinal Health (NYSE:CAH) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Cardinal Health had 9 more articles in the media than Ridgetech. MarketBeat recorded 11 mentions for Cardinal Health and 2 mentions for Ridgetech. Cardinal Health's average media sentiment score of 1.03 beat Ridgetech's score of 0.79 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	7 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cardinal Health has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Cardinal Health	$254.25B	0.22	$1.71B	$7.23	32.83

Ridgetech has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

Cardinal Health has a consensus target price of $266.56, indicating a potential upside of 12.32%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts clearly believe Cardinal Health is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84

Cardinal Health has a net margin of 0.67% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cardinal Health	0.67%	-98.53%	4.69%

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 0.1% of Cardinal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Cardinal Health beats Ridgetech on 12 of the 14 factors compared between the two stocks.

Get Ridgetech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDGT vs. The Competition

Export

Metric	Ridgetech	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.18M	$9.81B	$7.16B	$13.21B
Dividend Yield	N/A	2.61%	2.53%	16.37%
P/E Ratio	N/A	34.10	275.30	26.16
Price / Sales	0.03	4.87	635.99	108.09
Price / Cash	N/A	115.75	76.38	53.09
Price / Book	0.02	5.11	11.22	6.33
Net Income	-$1.25M	$315.68M	$3.50B	$382.15M
7 Day Performance	15.57%	-0.38%	-0.89%	-1.40%
1 Month Performance	19.91%	-1.97%	-4.42%	-3.47%
1 Year Performance	-99.50%	12.76%	7.03%	1.18%

Ridgetech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDGT Ridgetech	0.6076 of 5 stars	$1.01 +15.5%	N/A	-99.5%	$3.18M	$132.16M	N/A	980
MEDS Wellgistics Health	0.29 of 5 stars	$2.88 -6.2%	N/A	-91.6%	$9.21M	$8.02M	N/A	31	Analyst Downgrade Gap Down
HKPD Hong Kong Pharma Digital Technology	1.4633 of 5 stars	$0.10 +0.8%	N/A	-91.4%	$1.70M	$13.43M	N/A	11	Positive News Short Interest Decrease Gap Down
MCK McKesson	4.6509 of 5 stars	$908.99 -1.4%	$973.19 +7.1%	+23.7%	$105.98B	$403.43B	24.32	43,000	Trending News Analyst Forecast
COR Cencora	4.7835 of 5 stars	$316.68 +0.1%	$372.07 +17.5%	+3.0%	$60.43B	$321.33B	23.53	51,000	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDGT) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ridgetech (RDGT) Competitors

RDGT vs. MEDS, HKPD, MCK, COR, and CAH

How does Ridgetech compare to Wellgistics Health?

Summary

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Summary

How does Ridgetech compare to McKesson?

Summary

How does Ridgetech compare to Cencora?

Summary

How does Ridgetech compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ridgetech (RDGT) Competitors

RDGT vs. MEDS, HKPD, MCK, COR, and CAH

How does Ridgetech compare to Wellgistics Health?

Do insiders and institutionals hold more shares of RDGT or MEDS?

Does the media prefer RDGT or MEDS?

Which has stronger earnings and valuation, RDGT or MEDS?

Is RDGT or MEDS more profitable?

Do analysts prefer RDGT or MEDS?

Which has more risk and volatility, RDGT or MEDS?

Summary

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Which has better earnings and valuation, HKPD or RDGT?

Do analysts prefer HKPD or RDGT?

Does the media refer more to HKPD or RDGT?

Which has more volatility & risk, HKPD or RDGT?

Is HKPD or RDGT more profitable?

Do insiders and institutionals believe in HKPD or RDGT?

Summary

How does Ridgetech compare to McKesson?

Do insiders & institutionals hold more shares of RDGT or MCK?

Which has more risk & volatility, RDGT or MCK?

Does the media prefer RDGT or MCK?

Which has preferable earnings and valuation, RDGT or MCK?

Is RDGT or MCK more profitable?

Do analysts prefer RDGT or MCK?

Summary

How does Ridgetech compare to Cencora?

Which has more volatility and risk, COR or RDGT?

Is COR or RDGT more profitable?

Which has preferable earnings & valuation, COR or RDGT?

Do analysts rate COR or RDGT?

Do insiders & institutionals have more ownership in COR or RDGT?

Does the media refer more to COR or RDGT?

Summary

How does Ridgetech compare to Cardinal Health?

Does the media prefer RDGT or CAH?

Which has preferable earnings & valuation, RDGT or CAH?

Which has more risk & volatility, RDGT or CAH?

Do analysts rate RDGT or CAH?

Is RDGT or CAH more profitable?

Do insiders and institutionals believe in RDGT or CAH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools